Birdwatch Archive

Birdwatch Note

2024-10-09 14:05:05 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

本年10月8日のイベント直前に明治製菓ファルマの小林社長が製品化されたコスタイベ(レプリコンワクチン)を世界で最初に打ちました https://www.mixonline.jp/tabid55.html?artid=77254 よって、「一万人以上被害を出している」わけがありません。 コスタイベの治験で死亡はプラセボ群が16(うち、新型コロナ9)接種群では5(うち、新型コロナ1)と減少しており、特段の懸念は認められません https://doi.org/10.1038/s41467-024-47905-1 https://www.mhlw.go.jp/content/10906000/001266060.pdf 従来型も、日本を含めた世界中の継続かつ徹底した科学的検証でワクチンによる被害は全くないか、極めて稀である可能性が高いと言えます https://www.mhlw.go.jp/content/10900000/000796742.pdf https://www.niid.go.jp/niid/ja/others.html https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines-safety https://doi.org/10.1016/S1473-3099(22)00320-6 https://warp.ndl.go.jp/info:ndljp/pid/13123205/www.cov19-vaccine.mhlw.go.jp/qa/0081.html https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa.html#29 https://www.mhlw.go.jp/stf/shingi/shingi-kousei_284075.html ただし、1億回に1人程度の被害がないとまでは言い切れません

Written by EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1843854843934585322

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1844016234960175482
  • noteId - 1844016234960175482
  • participantId -
  • noteAuthorParticipantId - EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00 Participant Details
  • createdAtMillis - 1728482705236
  • tweetId - 1843854843934585322
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • 本年10月8日のイベント直前に明治製菓ファルマの小林社長が製品化されたコスタイベ(レプリコンワクチン)を世界で最初に打ちました https://www.mixonline.jp/tabid55.html?artid=77254 よって、「一万人以上被害を出している」わけがありません。 コスタイベの治験で死亡はプラセボ群が16(うち、新型コロナ9)接種群では5(うち、新型コロナ1)と減少しており、特段の懸念は認められません https://doi.org/10.1038/s41467-024-47905-1 https://www.mhlw.go.jp/content/10906000/001266060.pdf 従来型も、日本を含めた世界中の継続かつ徹底した科学的検証でワクチンによる被害は全くないか、極めて稀である可能性が高いと言えます https://www.mhlw.go.jp/content/10900000/000796742.pdf https://www.niid.go.jp/niid/ja/others.html https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines-safety https://doi.org/10.1016/S1473-3099(22)00320-6 https://warp.ndl.go.jp/info:ndljp/pid/13123205/www.cov19-vaccine.mhlw.go.jp/qa/0081.html https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa.html#29 https://www.mhlw.go.jp/stf/shingi/shingi-kousei_284075.html ただし、1億回に1人程度の被害がないとまでは言い切れません

Note Ratings

rated at rated by
2024-10-10 18:30:44 -0500 Rating Details
2024-10-10 14:06:32 -0500 Rating Details
2024-10-09 22:24:37 -0500 Rating Details
2024-10-09 22:22:31 -0500 Rating Details
2024-10-09 19:10:42 -0500 Rating Details
2024-10-09 18:21:13 -0500 Rating Details
2024-10-09 15:04:16 -0500 Rating Details
2024-10-09 13:23:22 -0500 Rating Details
2024-10-09 11:44:27 -0500 Rating Details
2024-10-09 11:18:01 -0500 Rating Details
2024-10-09 10:15:46 -0500 Rating Details
2024-10-09 09:57:17 -0500 Rating Details
2024-10-09 20:41:14 -0500 Rating Details
2024-10-09 19:47:30 -0500 Rating Details
2024-10-09 19:03:09 -0500 Rating Details
2024-10-09 19:00:04 -0500 Rating Details
2024-10-09 18:40:27 -0500 Rating Details
2024-10-09 18:17:17 -0500 Rating Details
2024-10-09 15:41:00 -0500 Rating Details
2024-10-09 15:10:54 -0500 Rating Details
2024-10-09 15:03:20 -0500 Rating Details
2024-10-09 10:08:45 -0500 Rating Details
2024-10-09 10:01:31 -0500 Rating Details
2024-10-09 09:37:59 -0500 Rating Details
2024-10-10 17:32:45 -0500 Rating Details
2024-10-10 07:25:46 -0500 Rating Details
2024-10-09 23:43:09 -0500 Rating Details
2024-10-09 19:57:34 -0500 Rating Details
2024-10-09 19:43:53 -0500 Rating Details
2024-10-09 17:14:08 -0500 Rating Details
2024-10-09 16:38:48 -0500 Rating Details
2024-10-09 15:16:25 -0500 Rating Details
2024-10-09 13:31:12 -0500 Rating Details
2024-10-09 11:23:50 -0500 Rating Details
2024-10-09 10:11:21 -0500 Rating Details
2024-10-09 10:05:21 -0500 Rating Details
2024-10-09 10:03:41 -0500 Rating Details
2024-10-09 09:53:45 -0500 Rating Details
2024-10-09 09:38:58 -0500 Rating Details
2024-10-26 13:16:50 -0500 Rating Details
2024-10-11 23:51:06 -0500 Rating Details
2024-10-09 23:17:48 -0500 Rating Details
2024-10-09 23:15:45 -0500 Rating Details
2024-10-09 20:05:56 -0500 Rating Details
2024-10-09 19:25:36 -0500 Rating Details
2024-10-09 17:33:35 -0500 Rating Details
2024-10-09 17:13:17 -0500 Rating Details
2024-10-09 16:44:04 -0500 Rating Details
2024-10-09 14:54:42 -0500 Rating Details
2024-10-09 12:08:47 -0500 Rating Details
2024-10-09 11:19:14 -0500 Rating Details
2024-10-09 10:48:50 -0500 Rating Details
2024-10-09 10:20:06 -0500 Rating Details
2024-10-09 10:16:04 -0500 Rating Details
2024-10-09 09:49:25 -0500 Rating Details
2024-10-09 19:58:06 -0500 Rating Details
2024-10-09 19:36:11 -0500 Rating Details
2024-10-09 18:46:56 -0500 Rating Details
2024-10-09 18:09:28 -0500 Rating Details
2024-10-09 17:56:39 -0500 Rating Details
2024-10-09 17:40:42 -0500 Rating Details
2024-10-09 17:22:49 -0500 Rating Details
2024-10-09 17:03:24 -0500 Rating Details
2024-10-09 12:13:46 -0500 Rating Details
2024-10-09 11:40:50 -0500 Rating Details
2024-10-09 11:03:24 -0500 Rating Details
2024-10-09 10:20:48 -0500 Rating Details
2024-10-09 10:13:46 -0500 Rating Details
2024-10-09 09:36:03 -0500 Rating Details